Caenorhabditis elegans: in vivo study model of bacterial virulence;Caenorhabditis elegans : modèle d'étude in vivo de la virulence bactérienne

Pathologie Biologie

Volumn 54, Issue 8-9 SPEC.ISS., 2006, Pages 439-446

  Lavigne, J P ^a,b   Blanc Potard, A B ^c   Bourg, G ^c   O'Callaghan, D ^c   Sotto, A ^b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b Laboratoire universitaire d'antibiologie   (France)

^c INSERM   (France)

Author keywords

Bacterial virulence; Caenorhabditis elegans; Escherichia coli

Indexed keywords

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CAENORHABDITIS ELEGANS; IN VIVO STUDY; NONHUMAN; PATHOGENESIS; ANIMAL; BACTERIAL INFECTION; DISEASE MODEL; ENTEROBACTER INFECTION; ESCHERICHIA COLI; HUMAN; MICROBIOLOGY; PATHOGENICITY; REPRODUCIBILITY; VIRULENCE;

ANIMALS; BACTERIAL INFECTIONS; CAENORHABDITIS ELEGANS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; REPRODUCIBILITY OF RESULTS; VIRULENCE;

EID: 33751087028     PISSN: 03698114     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.patbio.2006.07.011     Document Type: Article

References (74)

1. Chauvet S., and Ewbank J.J. Caenorhabditis elegans : un modèle d'étude des interactions hôte-organisme pathogène. Med. Sci. (Paris) 16 (2000) 912-916
2. Hoffmann J.A., Kafatos F.C., Janeway C.A., and Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 284 (1999) 1313-1318
3. Pradel E., and Ewbank J.J. Genetic models in pathogenesis. Annu. Rev. Genet. 38 (2004) 347-363
4. Steinert M., and Heuner K. Dictyostelium as host model for pathogenesis. Cell. Microbiol. 7 (2005) 307-314
5. Steinert M., Leippe M., and Roeder T. Surrogate hosts: protozoa and invertebrates as models for studying pathogen-host interactions. Int. J. Med. Microbiol. 293 (2003) 321-332
6. Hariharan I.K., and Haber D.A. Yeast, flies, worms and fish in the study of human disease. N. Engl. J. Med. 348 (2003) 2457-2463
7. Mochii M., Yoshida S., Morita K., Kohara Y., and Ueno N. Identification of transforming growth factor-beta- regulated genes in Caenorhabditis elegans by differential hybridization of arrayed cDNAs. Proc. Natl. Acad. Sci. USA 96 (1999) 15020-15025
8. Couillault C., and Ewbank J.J. Diverse bacteria are pathogens of Caenorhabditis elegans. Infect. Immun. 70 (2002) 4705-4707
9. Hodgkin J., Kuwabara P.E., and Corneliussen B. A novel bacterial pathogen, Microbacterium nematophilum, induces morphological change in the nematode C. elegans. Curr. Biol. 10 (2000) 1615-1618
10. Garsin D.A., Sifri C.D., Mylonakis E., Qin X., Singh K.V., Murray B.E., et al. A simple model host for identifying Gram-positive virulence factors. Proc. Natl. Acad. Sci. USA 98 (2001) 10892-10897
11. Mylonakis E., Ausubel F.M., Perfect J.R., Heitman J., and Calderwood S.B. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. USA 99 (2002) 15675-15680
12. Ewbank J.J. Tackling both sides of the host-pathogen equation with Caenorhabditis elegans. Microbes Infect. 4 (2002) 247-256
13. Alegado R.A., Campbell M.C., Chen W.C., Slutz S.S., and Tan M.W. Characterization of mediators of microbial virulence and innate immunity using the Caenorhabditis elegans host-pathogen model. Cell. Microbiol. 5 (2003) 435-444
14. Nicholas H.R., and Hodgkin J. Responses to infection and possible recognition strategies in the innate immune system of Caenorhabditis elegans. Mol. Immunol. 41 (2004) 479-493
15. Schulenburg H., and Ewbank J.J. Diversity and specificity in the interaction between Caenorhabditis elegans and the pathogen Serratia marcescens. BMC Evol. Biol. 4 (2004) 49
16. Sifri C.D., Begun J., and Ausubel F.M. The worm has turned--microbial virulence modeled in Caenorhabditis elegans. Trends Microbiol. 13 (2005) 119-127
17. Kothe M., Antl M., Huber B., Stoecker K., Ebrecht D., Steinmetz I., et al. Killing of Caenorhabditis elegans by Burkholderia cepacia is controlled by the cep quorum-sensing system. Cell. Microbiol. 5 (2003) 343-351
18. Tan M.W., Mahajan-Miklos S., and Ausubel F.M. Killing of Caenorhabditis elegans by Pseudomonas aeruginosa used to model mammalian bacterial pathogenesis. Proc. Natl. Acad. Sci. USA 96 (1999) 715-720
19. Mahajan-Miklos S., Tan M.W., Rahme L.G., and Ausubel F.M. Molecular mechanisms of bacterial virulence elucidated using a Pseudomonas aeruginosa-Caenorhabditis elegans pathogenesis model. Cell 96 (1999) 47-56
20. Darby C., Hsu J.W., Ghori N., and Falkow S. Caenorhabditis elegans: plague bacteria biofilm blocks food intake. Nature 417 (2002) 243-244
21. Joshua G.W., Karlyshev A.V., Smith M.P., Isherwood K.E., Titball R.W., and Wren B.W. A Caenorhabditis elegans model of Yersinia infection: biofilm formation on a biotic surface. Microbiol. 149 (2003) 3221-3229
22. Mylonakis E., and Aballay A. Worms and flies as genetically tractable animal models to study host-pathogen interactions. Infect. Immun. 73 (2005) 3833-3841
23. Pujol N., Link E.M., Liu L.X., Kurz C.L., Alloing G., Tan M.W., et al. A reverse genetic analysis of components of the Toll signaling pathway in Caenorhabditis elegans. Curr. Biol. 11 (2001) 809-821
24. Tan M.W., and Ausubel F.M. Caenorhabditis elegans: a model genetic host to study Pseudomonas aeruginosa pathogenesis. Curr. Opin. Microbiol. 3 (2000) 29-34
25. Aballay A., and Ausubel F.M. Programmed cell death mediated by ced-3 and ced-4 protects Caenorhabditis elegans from Salmonella typhimurium-mediated killing. Proc. Natl. Acad. Sci. USA 98 (2001) 2735-2739
26. ONERBA. Observatoire National de l'Epidémiologie de la Résistance Bactérienne aux Antibiotiques. [Online.] 2006 January [cited 2005 September]. Available from http://www.onerba.org.
27. Bonnet R. Growing group of extended-spectrum beta-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48 (2004) 1-14
28. Conceicao T., Brizio A., Duarte A., Lito L.M., Cristino J.M., and Salgado M.J. First description of CTX-M-15-producing Klebsiella pneumoniae in Portugal. Antimicrob. Agents Chemother. 49 (2005) 477-478
29. Moubareck C., Doucet-Populaire F., Hamze M., Daoud Z., and Weill F.X. First extended-spectrum-ß-lactamase (CTX-M-15)-producing Salmonella enterica serotype Typhimurium isolate identified in Lebanon. Antimicrob. Agents Chemother. 49 (2005) 864-865
30. Winokur P.L., Canton R., Casellas J.M., and Legakis N. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32 (2001) (S94-103)
31. Baraniak A., Fiett A., Sulikowska J., Nordmann P., and Gniadkowski M. Countrywide spread of CTX-M-3 extended-spectrum beta-lactamase-producing microorganisms of the family Enterobacteriaceae in Poland. Antimicrob. Agents Chemother. 46 (2002) 151-159
32. Boyd D.A., Tyler S., Christianson S., McGeer A., Muller M.P., Willey B.M., et al. Complete nucleotide sequence of a 92-kilobase plasmid harboring the CTX-M-15 extended-spectrum beta-lactamase involved in an outbreak in long-term-care facilities in Toronto, Canada. Antimicrob. Agents Chemother. 48 (2004) 3758-3764
33. Brigante G., Luzzaro F., Perilli M., Lombardi G., Coli A., Rossolini G.M., et al. Evolution of CTX-M-type ß-lactamases in isolates of Escherichia coli infecting hospital and community patients. Int. J. Antimicrob. Agents 25 (2005) 157-162
34. Eckert C., Gautier V., Saladin-Allard M., Hidri N., Verdet C., Ould-Hocine Z., et al. Dissemination of CTX-M-type beta-lactamases among clinical isolates of Enterobacteriaceae in Paris, France. Antimicrob. Agents Chemother. 48 (2004) 1249-1255
35. Gangoue-Pieboji J., Miriagou V., Vourli S., Tzelepi E., Ngassam P., and Tzouvelekis L.S. Emergence of CTX-M-15-producing enterobacteria in Cameroon and characterization of a blaCTX-M-15-carrying element. Antimicrob. Agents Chemother. 49 (2005) 441-443
36. Lavigne J.P., Bouziges N., Chanal C., Mahamat A., Michaux-Charachon S., and Sotto A. Molecular epidemiology of Enterobacteriaceae isolates producing extended-spectrum β-lactamases in a French hospital. J. Clin. Microbiol. 40 (2004) 3805-3808
37. Leflon-Guibout V., Jurand C., Bonacorsi S., Espinasse F., Guelfi M.C., Duportail F., et al. Emergence and spread of three clonally related virulent isolates of CTX-M-15-producing Escherichia coli with variable resistance to aminoglycosides and tetracycline in a French geriatric hospital. Antimicrob. Agents Chemother. 48 (2004) 3736-3742
38. Pitout J.D., Nordmann P., Laupland K.B., and Poirel L. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 56 (2005) 52-59
39. Hacker J., Blum-Oehler G., Muhldorfer I., and Tschape H. Pathogenicity islands of virulent bacteria: structure, function and impact on microbial evolution. Mol. Microbiol. 23 (1997) 1089-1097
40. Johnson J.R. Virulence factors in Escherichia coli urinary tract infection. Clin. Microbiol. Rev. 4 (1991) 80-128
41. Johnson J.R., and Stell A.L. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181 (2000) 261-272
42. Oelschlaeger T.A., Dobrindt U., and Hacker J. Virulence factors of uropathogens. Curr. Opin. Urol. 12 (2002) 33-38
43. Branger C., Zamfir O., Geoffroy S., Laurans G., Arlet G., Thien H.V., et al. Genetic background of Escherichia coli and Extended-spectrum β-Lactamase Type. Emerg. Infect. Dis. 11 (2005) 54-61
44. Drews S.J., Poutanen S.M., Mazzulli T., McGeer A.J., Sarabia A., Pong-Porter S., et al. Decreased Prevalence of Virulence Factors among Ciprofloxacin-Resistant Uropathogenic Escherichia coli Isolates. J. Clin. Microbiol. 43 (2005) 4218-4220
45. Horcajada J.P., Soto S., Gajewski A., Smithson A., Jimenez de Anta M.T., Mensa J., et al. Quinolone-resistant uropathogenic Escherichia coli strains from phylogenetic group B2 have fewer virulence factors than their susceptible counterparts. J. Clin. Microbiol. 43 (2005) 2962-2964
46. Johnson J.R., van der Schee C., Kuskowski M.A., Goessens W., and van Belkum A. Phylogenetic background and virulence profiles of fluoroquinolone-resistant clinical Escherichia coli isolates from the Netherlands. J. Infect. Dis. 186 (2002) 1852-1856
47. Johnson J.R., Kuskowski M.A., Owens K., Gajewski A., and Winokur P.L. Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extended-spectrum cephalosporins and cephamycins among Escherichia coli isolates from animals and humans. J. Infect. Dis. 188 (2003) 759-768
48. Johnson J.R., Kuskowski M.A., O'Bryan T.T., Colodner R., and Raz R. Virulence genotype and phylogenetic origin in relation to antibiotic resistance profile among Escherichia coli urine sample isolates from Israeli women with acute uncomplicated cystitis. Antimicrob. Agents Chemother. 49 (2005) 26-31
49. Vila J., Simon K., Ruiz J., Horcajada J.P., Velasco M., Barranco M., et al. Are quinolone-resistant uropathogenic Escherichia coli less virulent?. J. Infect. Dis. 186 (2002) 1039-1042
50. Pitout J.D., Laupland K.B., Church D.L., Menard M.L., and Johnson J.R. Virulence factors of Escherichia coli isolates that produce CTX-M-type extended-spectrum beta-lactamases. Antimicrob. Agents Chemother. 49 (2005) 4667-4670
51. Anyanful A., Dolan-Livengood J.M., Lewis T., Sheth S., Dezalia M.N., Sherman M.A., et al. Paralysis and killing of Caenorhabditis elegans by enteropathogenic Escherichia coli requires the bacterial tryptophanase gene. Mol. Microbiol. 57 (2005) 988-1007
52. Lavigne J.P., Blanc-Potard A.B., Bourg G., Moreau J., Chanal C., Bouziges N., et al. Virulence genotype and nematode killing properties of extraintestinal Escherichia coli producing CTX-M beta-lactamases. Clin. Microbiol. Infect. (2006) (In press)
53. O'Quinn A.L., Wiegand E.M., and Jeddeloh J.A. Burkholderia pseudomallei kills the nematode Caenorhabditis elegans using an endotoxin-mediated paralysis. Cell. Microbiol. 3 (2001) 381-393
54. Balaji V., Jesudason M.V., Sridharan G., and Subramanian K. Detection of virulence attributes of Burkholderia pseudomallei. Indian J. Med. Res. 119 (2004) 101-106
55. Chua K.L., Chan Y.Y., and Gan Y.H. Flagella are virulence determinants of Burkholderia pseudomallei. Infect. Immun. 71 (2003) 1622-1629
56. Essex-Lopresti A.E., Boddey J.A., Thomas R., Smith M.P., Hartley M.G., Atkins T., et al. A type IV pilin, PilA, Contributes To Adherence of Burkholderia pseudomallei and virulence in vivo. Infect. Immun. 73 (2005) 1260-1264
57. Darby C., Cosma C.L., Thomas J.H., and Manoil C. Lethal paralysis of Caenorhabditis elegans by Pseudomonas aeruginosa. Proc. Natl. Acad. Sci. USA 96 (1999) 15202-15207
58. Hodgkin J. Pseudomonas pathogenicity. Trends Genet. 15 (1999) 139
59. Aballay A., Drenkard E., Hilbun L.R., and Ausubel F.M. Caenorhabditis elegans innate immune response triggered by Salmonella enterica requires intact LPS and is mediated by a MAPK signaling pathway. Curr. Biol. 13 (2003) 47-52
60. Aballay A., Yorgey P., and Ausubel F.M. Salmonella typhimurium proliferates and establishes a persistent infection in the intestine of Caenorhabditis elegans. Curr. Biol. 10 (2000) 1539-1542
61. Aballay A., and Ausubel F.M. Caenorhabditis elegans as a host for the study of host-pathogen interactions. Curr. Opin. Microbiol. 5 (2002) 97-101
62. Tenor J.L., McCormick B.A., Ausubel F.M., and Aballay A. Caenorhabditis elegans-based screen identifies Salmonella virulence factors required for conserved host-pathogen interactions. Curr. Biol. 14 (2004) 1018-1024
63. Kurz C.L., Chauvet S., Andres E., Aurouze M., Vallet I., Michel G.P., et al. Virulence factors of the human opportunistic pathogen Serratia marcescens identified by in vivo screening. EMBO J. 22 (2003) 1451-1460
64. Kurz C.L., and Ewbank J.J. Caenorhabditis elegans for the study of host-pathogen interactions. Trends Microbiol. 8 (2000) 142-144
65. Marroquin L.D., Elyassnia D., Griffitts J.S., Feitelson J.S., and Aroian R.V. Bacillus thuringiensis (Bt) toxin susceptibility and isolation of resistance mutants in the nematode Caenorhabditis elegans. Genetics 155 (2000) 1693-1699
66. Sifri C.D., Mylonakis E., Singh K.V., Qin X., Garsin D.A., Murray B.E., et al. Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect. Immun. 70 (2002) 5647-5650
67. Moy T.I., Mylonakis E., Calderwood S.B., and Ausubel F.M. Cytotoxicity of hydrogen peroxide produced by Enterococcus faecium. Infect. Immun. 72 (2004) 4512-4520
68. Sifri C.D., Baresch-Bernal A., Calderwood S.B., and von Eiff C. Virulence of Staphylococcus aureus small colony variants in the Caenorhabditis elegans infection model. Infect. Immun. 74 (2006) 1091-1096
69. Sifri C.D., Begun J., Ausubel F.M., and Calderwood S.B. Caenorhabditis elegans as a model host for Staphylococcus aureus pathogenesis. Infect. Immun. 71 (2003) 2208-2217
70. Jansen W.T., Bolm M., Balling R., Chhatwal G.S., and Schnabel R. Hydrogen peroxide-mediated killing of Caenorhabditis elegans by Streptococcus pyogenes. Infect. Immun. 70 (2002) 5202-5207
71. Thomsen L.E., Slutz S.S., Tan M.W., and Ingmer H. Caenorhabditis elegans is a model host for Listeria monocytogenes. Appl. Environ. Microbiol. 72 (2006) 1700-1701
72. Park J.O., El-Tarabily K.A., Ghisalberti E.L., and Sivasithamparam K. Pathogenesis of Streptoverticillium albireticuli on Caenorhabditis elegans and its antagonism to soil-borne fungal pathogens. Lett. Appl. Microbiol. 35 (2002) 361-365
73. Darby C., Ananth S.L., Tan L., and Hinnebusch B.J. Identification of gmhA, a Yersinia pestis gene required for flea blockage, by using a Caenorhabditis elegans biofilm system. Infect. Immun. 73 (2005) 7236-7242
74. Gravato-Nobre M.J., Nicholas H.R., Nijland R., O'Rourke D., Whittington D.E., Yook K.J., et al. Multiple genes affect sensitivity of Caenorhabditis elegans to the bacterial pathogen Microbacterium nematophilum. Genetics 171 (2005) 1033-1045